文献速递肿瘤 PET/CT

监督机器学习实现[68Ga]Ga-PSMA-11 PET/MRI对原发性前列腺癌的无创病灶表征

Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-12-19

本研究纳入52例接受[18F]FMC和[68Ga]Ga-PSMA-11双示踪剂PET/MRI及根治性前列腺切除术的原发性前列腺癌患者,采用影像组学联合集成机器学习建立低危vs高危病灶预测模型(MLH),并构建生化复发(BCR)和总体患者风险(OPR)预测模型。MLH模型AUC为0.86,高于[68Ga]Ga-PSMA-11 SUVmax分析的0.80;MBCR和MOPR模型经1000折蒙特卡洛交叉验证的准确率分别为89%和91%,AUC分别为0.90和0.94,而基于PSA、活检Gleason评分和TNM分期的常规分析预测BCR和OPR的准确率仅为69%和70%。结论提示基于PET/MRI影像组学和机器学习可在无需活检的情况下提升原发性前列腺癌风险分类。

要点

  • MLH模型AUC 0.86,优于[68Ga]Ga-PSMA-11 SUVmax分析的0.80。
  • MBCR和MOPR模型准确率89%和91%,AUC 0.90和0.94。
  • 常规PSA、Gleason评分和TNM分期预测BCR和OPR准确率仅69%和70%。

核心结论

  • 基于PET/MRI影像组学和机器学习可在无需活检采样的情况下提升原发性前列腺癌患者的风险分类。

研究设计与样本

  • 单中心随机前瞻性试验(NCT02659527)的预试验,纳入52例2014至2015年间接受[18F]FMC和[68Ga]Ga-PSMA-11双示踪剂PET/MRI及根治性前列腺切除术的患者。
  • 应用影像组学联合集成机器学习,整合[68Ga]Ga-PSMA-11 PET、表观扩散系数和横向弛豫时间加权MRI扫描建立低危vs高危病灶预测模型(MLH)。
  • 结合MLH、PSA和临床分期值构建MBCR和MOPR预测模型,采用1000折蒙特卡洛交叉验证评估性能,并与常规[68Ga]Ga-PSMA-11 SUV分析比较。

主要发现

  • MLH模型的受试者工作特征曲线下面积(AUC)为0.86,高于[68Ga]Ga-PSMA-11 SUVmax分析的0.80。
  • 蒙特卡洛交叉验证显示MBCR和MOPR模型的准确率分别为89%和91%,AUC分别为0.90和0.94。
  • 基于PSA、活检Gleason评分和TNM分期的标准常规分析预测BCR和OPR的准确率分别为69%和70%。

关键数值与推荐

  • MLH模型AUC 0.86 vs [68Ga]Ga-PSMA-11 SUVmax分析AUC 0.80。
  • MBCR模型准确率89%、AUC 0.90;MOPR模型准确率91%、AUC 0.94(1000折蒙特卡洛交叉验证)。
  • 常规分析(PSA、活检Gleason评分、TNM分期)预测BCR准确率69%、预测OPR准确率70%。

临床怎么用

  • 对于原发性前列腺癌患者,可考虑采用[68Ga]Ga-PSMA-11 PET/MRI影像组学联合机器学习模型进行无创风险分层,辅助预测生化复发和总体患者风险。

局限性

  • 本研究为单中心预试验,样本量52例,结果需更大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Risk classification of primary prostate cancer in clinical routine is mainly based on prostate-specific antigen (PSA) levels, Gleason scores from biopsy samples, and tumor-nodes-metastasis (TNM) staging. This study aimed to investigate the diagnostic performance of positron emission tomography/magnetic resonance imaging (PET/MRI) in vivo models for predicting low-vs-high lesion risk (LH) as well as biochemical recurrence (BCR) and overall patient risk (OPR) with machine learning. METHODS: Fifty-two patients who underwent multi-parametric dual-tracer [18F]FMC and [68Ga]Ga-PSMA-11 PET/MRI as well as radical prostatectomy between 2014 and 2015 were included as part of a single-center pilot to a randomized prospective trial (NCT02659527). Radiomics in combination with ensemble machine learning was applied including the [68Ga]Ga-PSMA-11 PET, the apparent diffusion coefficient, and the transverse relaxation time-weighted MRI scans of each patient to establish a low-vs-high risk lesion prediction model (MLH). Furthermore, MBCR and MOPR predictive model schemes were built by combining MLH, PSA, and clinical stage values of patients. Performance evaluation of the established models was performed with 1000-fold Monte Carlo (MC) cross-validation. Results were additionally compared to conventional [68Ga]Ga-PSMA-11 standardized uptake value (SUV) analyses. RESULTS: The area under the receiver operator characteristic curve (AUC) of the MLH model (0.86) was higher than the AUC of the [68Ga]Ga-PSMA-11 SUVmax analysis (0.80). MC cross-validation revealed 89% and 91% accuracies with 0.90 and 0.94 AUCs for the MBCR and MOPR models respectively, while standard routine analysis based on PSA, biopsy Gleason score, and TNM staging resulted in 69% and 70% accuracies to predict BCR and OPR respectively. CONCLUSION: Our results demonstrate the potential to enhance risk classification in primary prostate cancer patients built on PET/MRI radiomics and machine learning without biopsy sampling.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Papp L, Spielvogel CP, Grubmüller B, et al. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI. Eur J Nucl Med Mol Imaging. 2020. PMID: 33341915. doi:10.1007/s00259-020-05140-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。